University of Notre Dame du Lac’s Alnylam Pharmaceuticals ALNY Stock Holding History

University of Notre Dame du Lac’s Portfolio ALNY Stock Details ALNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-31,101	Closed	-$2.91M	–	57
2019 Q1	$2.91M	Sell	31,101 -1,096	-3%	-$91.7K	0.65%	47
2018 Q4	$2.35M	Buy	32,197 +2,371	+8%	+$182K	0.57%	51
2018 Q3	$2.61M	Buy	29,826 +2,874	+11%	+$289K	0.49%	63
2018 Q2	$2.65M	Buy	26,952 +4,822	+22%	+$478K	0.51%	58
2018 Q1	$2.64M	Buy	22,130 +2,035	+10%	+$262K	0.49%	63
2017 Q4	$2.55M	Sell	20,095 -11,802	-37%	-$1.48M	0.53%	63
2017 Q3	$3.75M	Sell	31,897 -5,511	-15%	-$470K	1.04%	50
2017 Q2	$2.98M	Buy	+37,408	New	+$2.39M	0.88%	55

Other funds holding ALNY

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

University of Notre Dame du Lac's ALNY Position: Q2 2019 in Review

University of Notre Dame du Lac sold out of Alnylam Pharmaceuticals (ALNY) in Q2 2019, closing a stake of 31,101 shares — an estimated $2.91M sold.

University of Notre Dame du Lac first reported a position in ALNY in Q2 2017 and held it in 8 quarters. The position peaked at $3.75M in Q3 2017. 290 funds tracked by Wall St. Rank hold ALNY as of Q2 2019.

University of Notre Dame du Lac reported no remaining Alnylam Pharmaceuticals position as of Q2 2019 after selling out during the quarter.
University of Notre Dame du Lac sold 31,101 Alnylam Pharmaceuticals shares in Q2 2019, an estimated $2.91M.
University of Notre Dame du Lac first reported a position in Alnylam Pharmaceuticals in Q2 2017 and held it in 8 quarters.
University of Notre Dame du Lac's Alnylam Pharmaceuticals position peaked at $3.75M in Q3 2017.
290 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2019.

Based on University of Notre Dame du Lac's 13F filing for Q2 2019, filed 14 Aug 2019.